Mark S. Rouse

3.4k citations
62 papers · 2.7k indexed · h-index 31

Impact in

Papers in

Mark S. Rouse

62 papers receiving 2.6k citations

Peers

Mark S. Rouse
Comparison fields: 5 of 129
  • Clinical Biochemistry 517
  • Molecular Medicine 318
  • Infectious Diseases 1.1k
  • Applied Microbiology and Biotechnology 66
  • Epidemiology 951
Replace Kerryl E. Piper with:
Kerryl E. Piper United States
James S. Tan United States
Cédric Jacqueline France
Gordon D. Christensen United States
W. Zimmerli Switzerland
Elisabeth Presterl Austria
Norbert Lehn Germany
Kerryl E. Greenwood‐Quaintance United States
E. Nagy Hungary
Elisabeth Nagy Hungary
Mark S. Rouse relative to Kerryl E. Piper United States Kerryl E. Piper's profile →
Citations per field
00.5×1.5×
Kerryl E. Piper · 1×
Citations per year

Countries citing papers authored by Mark S. Rouse

Since Specialization
Citations

This map shows the geographic impact of Mark S. Rouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Rouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Rouse more than expected).

Fields of papers citing papers by Mark S. Rouse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Rouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Rouse. The network helps show where Mark S. Rouse may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark S. Rouse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark S. Rouse Line = papers co-authored together Mark S. Rouse links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200925
2 200980
3 200748
4 200719
5 200643
6 200669
7 200680
8 200623
9 200573
10 200430
11 200444
12 200381
13 200336
14 200234
15 200043
16 2000148
17 200017
18 1999123
19 19922
20 19848

About Mark S. Rouse

Mark S. Rouse is a scholar working on Clinical Biochemistry, Infectious Diseases, Molecular Medicine, Microbiology and Pharmacology, having authored 62 papers that have together received 2.7k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (32 papers), Infective Endocarditis Diagnosis and Management (18 papers), Bacterial Identification and Susceptibility Testing (14 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Orthopedic Infections and Treatments (13 papers), Streptococcal Infections and Treatments (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Clinical Biochemistry (517 citations), Molecular Medicine (318 citations), Infectious Diseases (1.1k citations), Applied Microbiology and Biotechnology (66 citations) and Epidemiology (951 citations). Mark S. Rouse has collaborated with scholars based in United States, South Korea and Belarus. Frequent co-authors include Robin Patel, James M. Steckelberg, Kerryl E. Piper, José Luís del Pozo, Jayawant N. Mandrekar, Walter R. Wilson, Arlen D. Hanssen, Nancy K. Henry, Franklin R. Cockerill and Duane M. Ilstrup. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Diagnostic Microbiology and Infectious Disease, Clinical Orthopaedics and Related Research, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026